Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Russo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|July 9, 2025
PROFET Predicts Continuous Gene Expression Dynamics from scRNA-seq Data to Elucidate Heterogeneity of Cancer Treatment ResponsesYu-Chen Cheng, Hyemin Gu, Thomas O McDonald, et al.
NPJ Breast Cancer|June 8, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancerAlbert Grinshpun, Douglas Russo, Wen Ma, et al.
NPJ Breast Cancer|February 13, 2026
Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancerPaolo Tarantino, Jaeyoon Cha, Busem Binboga Kurt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2022
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast CancerJunko Tsuji, Tianyu Li, Albert Grinshpun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast CancerCristina Guarducci, Agostina Nardone, Douglas Russo, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
The New England Journal of Medicine|September 28, 2022
GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Nature Communications|August 30, 2022
Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategyVictoria N Parikh, Alexander G Ioannidis, David Jimenez-Morales, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biorxiv : the Preprint Server for Biology|July 9, 2025
PROFET Predicts Continuous Gene Expression Dynamics from scRNA-seq Data to Elucidate Heterogeneity of Cancer Treatment ResponsesYu-Chen Cheng, Hyemin Gu, Thomas O McDonald, et al.
NPJ Breast Cancer|June 8, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancerAlbert Grinshpun, Douglas Russo, Wen Ma, et al.
NPJ Breast Cancer|February 13, 2026
Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancerPaolo Tarantino, Jaeyoon Cha, Busem Binboga Kurt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2022
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast CancerJunko Tsuji, Tianyu Li, Albert Grinshpun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast CancerCristina Guarducci, Agostina Nardone, Douglas Russo, et al.
Genome Medicine|June 27, 2026
ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistanceCristina Guarducci, Daniel Abravanel, Douglas Russo, et al.
The New England Journal of Medicine|September 28, 2022
GPRC5D-Targeted CAR T Cells for MyelomaSham Mailankody, Sean M Devlin, Jonathan Landa, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Nature Communications|August 30, 2022
Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategyVictoria N Parikh, Alexander G Ioannidis, David Jimenez-Morales, et al.
Pageof 2